-
Corynoline Targets Src/JNK Signaling in Osteosarcoma
2026-09-25
A 2025 study reports that corynoline suppresses osteosarcoma cell growth alongside G2/M arrest and mitochondrial apoptosis, with Src/JNK signaling implicated by molecular readouts and JNK-inhibitor experiments. Cell and xenograft results support further investigation, while the available evidence does not establish a direct molecular target or clinical efficacy.
-
Bovine Insulin in HBV–ER Stress Assay Design
2026-09-25
Bovine insulin can shape the metabolic baseline of cultured cells, but it should not be mistaken for a direct probe of HBV-driven ER stress. This article connects insulin-aware assay design with research on QRICH1, HMGB1, and hepatic fibrosis, highlighting controls that improve interpretation.
-
Thiothixene in Macrophage Efferocytosis Workflows
2026-09-24
Thiothixene offers researchers a useful way to examine macrophage efferocytosis alongside dopamine-related biology, with 2 μM reported for in vitro macrophage assays. This guide turns that starting point into a controlled workflow and explains why a small paroxetine pharmacokinetic study informs interpretation—but does not validate immune-cell mechanisms.
-
Oltipraz in Cell Assays: A Practical Nrf2 Guide
2026-09-24
A scenario-driven guide to using Oltipraz (SKU B5958) in viability and cytotoxicity workflows, with practical advice on solvent controls, dose selection, and interpretation. It distinguishes product-supported specifications from assay-specific recommendations and explains how Nrf2-related findings in MASLD research should—and should not—inform cell experiments.
-
Masitinib (AB1010): Research Workflow Guide
2026-09-23
Masitinib (AB1010) is a DMSO-compatible research inhibitor for experiments focused on KIT and PDGFRα/β, including selected cancer and mast-cell models. It is not a broad-spectrum kinase tool and is unsuitable for aqueous- or ethanol-based formulations; use assay-specific controls and validation rather than treating dossier potency values as universal working concentrations.
-
Calpain Inhibitor I, ALLN: Practical Workflow Guide
2026-09-23
Calpain Inhibitor I, ALLN (SKU A2602) is a research reagent for modulating calpain I/II and cathepsin B/L activity in apoptosis assay, inflammation research, and ischemia-reperfusion injury workflows. It is suitable for controlled laboratory studies, but its biochemical Ki values should not be treated as cellular dosing instructions, and the compound is not intended for diagnostic, therapeutic, or medical use.
-
EGF as a Translational Lever for Stemness Research
2026-09-22
Epidermal Growth Factor is more than a routine cell-culture supplement: it is a controllable input for studying EGFR-dependent growth, differentiation, epithelial repair, and potentially stem-like phenotypes. This thought-leadership article connects recombinant human EGF with a standardized 3D glioblastoma spheroid workflow, outlining how researchers can improve assay rigor, interpret stemness responsibly, and build more translationally useful experimental strategies.
-
SAG for Hedgehog Pathway Activation
2026-09-22
SAG provides a controllable way to activate Smoothened in pathway assays, astrocyte–neuron co-cultures, developmental models, and mitochondrial disease research. Its strongest use-case distinction is the ability to connect Hedgehog pathway readouts with functional neuroprotection and glial-state measurements.
-
LAMP1 Controls CXCL10-CXCR3 Macrophage Polarization
2026-09-21
The 2024 International Immunopharmacology study identifies LAMP1 as a context-dependent regulator of CXCL10-CXCR3 signaling and macrophage polarization. Its combination of pharmacological antagonism, LAMP1 knockdown, autophagy analysis, and a poly(I:C)-induced lung injury model shows why CXCR3 responses can differ between inflammatory and non-inflammatory macrophage states.
-
SMYD2–miR-125b Control of RCC Drug Resistance
2026-09-21
This study identifies SMYD2 as both a prognostic marker and a functional driver of clear cell renal cell carcinoma, linking epigenetic regulation to miR-125b, DKK3, P-glycoprotein, and multidrug resistance. Its combined clinical, molecular, cellular, and xenograft design provides a framework for testing whether SMYD2 inhibition can improve responses to conventional anticancer drugs, including fluorouracil.
-
Rice Stripe Virus NS3 Rewires Host Signaling
2026-09-20
Zhuang et al. show that Rice stripe virus NS3 dynamically engages the OsSnRK3.25–OsCBL1/3–OsRBOHF pathway to balance antiviral defense, tissue damage, pathogenicity, and vector transmission. The study provides a mechanistic model of virus–plant–planthopper co-survival in which NS3 abundance and phosphorylation state produce stage-dependent outcomes.
-
Dextromethorphan hydrobromide for Neuroprotection
2026-09-19
Build more reproducible excitotoxicity and ion-channel assays with Dextromethorphan hydrobromide, using concentration controls, orthogonal readouts, and solvent-aware handling. The workflow also shows how findings from structure-guided PDK4 inhibitor research can improve assay design without confusing metabolic-disease evidence with direct neuroprotection evidence.
-
Heparin Sodium as an HSPG Probe in Nanovesicle Assays
2026-09-18
Heparin sodium is best known as a glycosaminoglycan anticoagulant, but its structural relationship to heparan sulfate makes it a useful hypothesis-testing tool in nanovesicle uptake studies. This article connects coagulation controls with the HSPG-dependent Sertoli-cell findings reported for Cistanche deserticola nanovesicles.
-
IGF2BP3–FZD1/7 Drives TNBC Stemness and Resistance
2026-09-18
The reference study identifies IGF2BP3 as an m6A reader that stabilizes FZD1 and FZD7 transcripts, activates β-catenin signaling, and reinforces stem-like properties and carboplatin resistance in triple-negative breast cancer. Its findings suggest that disrupting the IGF2BP3–FZD1/7 axis may improve chemotherapy response, although the evidence remains preclinical and requires validation across models.
-
Calcitriol: From VDR Mechanism to Translation
2026-09-17
A mechanism-led guide to using Calcitriol as a translational research tool across VDR biology, endometrial decidualization, immune modulation, and Hedgehog signaling, with practical assay design and evidence boundaries.